BridgeMD
New treatment option for High Myopia
Official title Risk of Posterior Staphyloma in Highly Myopic Europeans : From Epidemiology to Anatomy.
ClinicalTrials.gov ID: NCT06949579
What this study is testing
What is blood sampling for DNA?
blood sampling for DNA is an investigational medicine, being studied as a potential treatment for high myopia.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- In this cross-sectionnal study the aim is to increase the understanding of posterior staphyloma through a unique European consortium. Therefore, all eligible patients that either visit the outpatient clinic at Radboud in Nimegen, the Netherlands, or visit University Hopital Puerta de HierroMajadahonda in Madrid, Spain, or visit University Hospital Cochin in Paris, France, and after consenting, will be included.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Adults with high myopia (axial length ≥ 26.00 mm or degree of myopia of at least -6 diopters), with and without posterior staphyloma
- Adults aged 18 years or over
- Patient with high myopia (axial length ≥ 26.00 mm or degree of myopia of at least -6 diopters), with good quality retinal imaging
- Patient who has signed a consent form to participate in the study
- Patient who is a beneficiary of a social security scheme or who is entitled to it
You likely can't join if
- Any systemic or ocular pathologies with an impact on the posterior segment of the eye
- Patient with a systemic pathology likely to affect the posterior segment of the eye:
- Diabetes
- Systemic inflammatory disease: sarcoidosis, rheumatoid arthritis, systemic lupus erythematosus, Horton's disease
- Patients with retinitis pigmentosa
- Patients with syndromic myopia
See the full eligibility criteria
- Adults with high myopia (axial length ≥ 26.00 mm or degree of myopia of at least -6 diopters), with and without posterior staphyloma
- Adults aged 18 years or over
- Patient with high myopia (axial length ≥ 26.00 mm or degree of myopia of at least -6 diopters), with good quality retinal imaging
- Patient who has signed a consent form to participate in the study
- Patient who is a beneficiary of a social security scheme or who is entitled to it
- Any systemic or ocular pathologies with an impact on the posterior segment of the eye
- Patient with a systemic pathology likely to affect the posterior segment of the eye:
- Diabetes
- Systemic inflammatory disease: sarcoidosis, rheumatoid arthritis, systemic lupus erythematosus, Horton's disease
- Patients with retinitis pigmentosa
- Patients with syndromic myopia
- Patients with myopia associated with a genetic disease such as hereditary vitreoretinopathy
- Patients under guardianship, curatorship or legal protection, as well as pregnant or breastfeeding women (article L1121-5 of the CSP).
The study team makes the final eligibility decision.
Where it's taking place
- Paris, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Paris, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.